Association between immune checkpoint inhibitors and uveitis in patients with lung cancer, renal cell carcinoma, or malignant melanoma
ICI use was associated with a higher risk of uveitis compared to non-ICI use, particularly among patients aged <75 years.
Authors
- Koji Oba (ORCID: https://orcid.org/0000-0001-5468-8988)
- Akira Okada (ORCID: https://orcid.org/0000-0001-6480-3388)
- Chikako Iwai (ORCID: https://orcid.org/0000-0001-8260-4200)
- Yohei Hashimoto (ORCID: https://orcid.org/0000-0002-7944-6923)
- Asahi Fujita (ORCID: https://orcid.org/0000-0003-2251-4363)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Takaaki Konishi
- Taisuke Jo (ORCID: https://orcid.org/0000-0003-4980-0589)
Institutions
- The University of Sydney (AU)
- University of Tokyo Health Sciences (JP)
- Department of Health (IE)
- Department of Health Services (NP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Canadian Journal of Ophthalmology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1016/j.jcjo.2025.02.010
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Ministry of Health, Labour and Welfare